// biotech innovation

All signals tagged with this topic

Gene therapy enables remote control of brain cells to stop seizures

Chemogenetics—the ability to activate or suppress specific neurons using engineered genes and small molecules—has moved from animal models into human patients, with Chinese researchers reporting seizure reduction in three epilepsy cases. The shift from treating symptoms with pharmaceuticals to rewriting cellular behavior itself opens pathways for conditions like Parkinson's, depression, and chronic pain where precision neural modulation could replace broad-spectrum drugs. Stable patient compliance and delivery remain unsolved problems, but the clinical proof-of-concept signals that targeted brain intervention is moving from theoretical to viable.

Biotech Startup Develops Temporary Tattoos That Last Weeks, Not Forever

CipherX's dissolving patch technology directly challenges the permanence assumption that has defined tattooing for millennia. It offers commitment-phobic consumers and brands testing skin-based advertising a middle ground between henna (days) and laser removal (expensive, painful). The 15-minute application time collapses the friction of traditional tattooing while the weeks-long duration extends far beyond current temporary options. This could position tattoos as a fashion item rather than identity statement, shifting economics in the tattoo industry and how dermatology approaches body modification.